6 months on tirzepatide 6-Month Plan: Just $139/month! My Entire Tirzepatide GLP-1 Weight

Description

Get started through a secure online assessment that only takes a few minutes to complete

Tirzepatide and injectable semaglutide were associated with the greatest weight loss after a year of treatment among several GLP-1 receptor agonists, a recent study showed.“Despite being the most recent medication approved for weight loss, tirzepatide [Zepbound, Eli Lilly] showed the greatest weight loss among the GLP-1 medications studied,&rdquo

The Phase 3 ATTAIN-1 trial had good results that led to this approval, but not all positive: 12.4% average weight loss (27.3 lbs) at highest dose Lower than the 15-20% weight loss seen with injectables Wegovy and Zepbound Nearly 1/4 of participants on the highest dose reported vomiting Vomiting rates are much higher than injectable GLP-1s However, there is likely a niche for Foundayo (along with the pill version of Wegovy) due to convenience: No refrigeration requirements or injection site reactions Eliminates barriers for patients avoiding injectables due to stigma, needle aversion, or storage constraints It's possible we could see this as a "maintenance" therapy after an initial injectable course